News

Dollar Tree posts second-quarter same-store sales lift of 3.7%

BY Michael Johnsen

CHESAPEAKE, Va. — Dollar Tree generated 3.7% in same-store sales for its second quarter ended Aug. 3, beating analyst estimates, and recorded $1.9 billion in consolidated net sales, an 8.8% increase. 

Shares of Dollar Tree closed Thursday at $53.13, 88 cents higher than the previous close. 

"I am pleased with our second-quarter performance," stated Bob Sasser, Dollar Tree CEO. "Sales, customer traffic, average ticket, earnings and operating margin all continue to grow. Customers are responding in record numbers to our outstanding values in both discretionary and consumable merchandise categories. Our stores are well-stocked with a terrific merchandise presentation for back-to-school and the fall selling season."

Over the course of the second quarter, Dollar Tree opened 81 stores, expanded or relocated 32 stores, and closed 2 stores. Retail selling square footage increased 7% compared to a year ago, to 41.9 million square feet.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Dollar General awards $2.5 million in grants to support youth literacy programs

BY Michael Johnsen

GOODLETTSVILLE, Tenn. — The Dollar General Literacy Foundation on Thursday awarded more than $2.5 million in grants to approximately 650 schools, nonprofits and literacy organizations to support youth literacy programs.

"Youth literacy grants from the Dollar General Literacy Foundation are awarded at the beginning of the academic year to help make a distinct impact on the communities we serve by supporting programs that improve education and enhance literacy," stated Rick Dreiling, Dollar General’s chairman and CEO. 

Since its inception in 1993, the Dollar General Literacy Foundation has awarded more than $84.9 million in grants to nonprofit organizations, helping more than 4.8 million individuals take their first steps toward literacy or continued education.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA approves Mylan antidepressant after company reaffirms efficacy

BY Alaric DeArment

PITTSBURGH — The Food and Drug Administration has approved a supplemental regulatory application from Mylan for a generic antidepressant that was subject last year to scrutiny by the agency amid reports of efficacy problems, Mylan said Thursday.

The drug maker announced the approval of its supplemental abbreviated new drug application, or sANDA, for bupropion hydrochloride extended-release tablets in the 300-mg strength. The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL.

Last year, the FDA requested makers of generic versions of Wellbutrin XL to conduct studies to determine whether their versions were equivalent to the branded drug following reports that a company’s generic version had lower efficacy. By law, all generic drugs must be as safe and effective as their branded counterparts.

Bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths had sales of about $503.3 million during the 12-month period that ended in June, according to IMS Health.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES